Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst George Hill maintains a Hold rating on Hims & Hers Health (HIMS) and raises the price target from $14 to $16.
May 07, 2024 | 4:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Deutsche Bank maintains a Hold rating on Hims & Hers Health and increases the price target from $14 to $16.
The increase in price target by Deutsche Bank suggests a positive outlook on the stock's future performance, potentially leading to increased investor interest and a short-term uptick in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100